Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

ARNA 4.22 -0.03 (-0.71%)
price chart
Trading Volume Shifts: Image Sensing Systems, Inc.(NASDAQ:ISNS), Arena ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) gained seven cents to finish the day at a closing price of $4.25, a 1.67% increase in value from the previous closing price.
Related articles »  
Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T ...
On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts' consensus estimate of ($0.11) by $0.14.
Advertising And The Belviq Re-Launch
July of 2014 marked the "re-launch" of the anti-obesity drug Belviq from Arena Pharmaceuticals (NASDAQ:ARNA) and marketing partner Eisai (OTCPK:ESALY). Belviq had its initial launch in June of ... Needless to say, Arena stock suffered because sales ...
Related articles »  
Arena Pharmaceuticals Posts Increased Revenue In Second Quarter
Arena Pharmaceuticals, Inc. (ARNA) reported financial results for the second quarter of its fiscal year 2014 (2QFY14) before the market opened today.
Arena Pharmaceuticals Provides Corporate Update and Reports Second ...  MarketWatch
Related articles »  
Shining on Major News: Google Inc (NASDAQ:GOOG), Arena Pharmaceuticals ...
On 25 AUG Google Inc (NASDAQ:GOOG) said it increased the range of its productivity applications on Apple Inc.'s iOS.
Related articles »  
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) fell approximately 3.7% after the company reported a net loss (excluding one-time items) of 12 cents per share in the second quarter of 2014 wider than the Zacks Consensus Estimate of loss of 11 cents.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Dips As Loss Goes Beyond ...  FinancialsTrend
Belviq Scripts Flat For Arena (ARNA)  Seeking Alpha (registration)
Related articles »  
Stock Runners: Delta Air Lines Inc. (NYSE:DAL), Arena Pharmaceuticals, Inc ...
On 20 AUG Delta Air Lines Inc. (NYSE:DAL) EVP Glen W. Hauenstein unloaded 47,328 shares of the stock on the open market in a transaction that occurred on Wednesday.
Related articles »  
Belviq Sales Rise 2%
Sales of the anti-obesity pill Belviq from Arena Pharmaceuticals (NASDAQ:ARNA) continued to buck the seasonality factor by bringing in a 2% increase in week over week sales according to industry tracker IMS Health.
Why Need to Watch : OncoMed Pharmaceuticals (NASDAQ:OMED), Arena ...
OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
Related articles »  
Notable Analyst Actions: Merrimack Pharmaceuticals Inc (NASDAQ:MACK ...
Anakytsts expect Merrimack Pharmaceuticals Inc (NASDAQ:MACK) to find a marketing partner for MM-398 outside the U.S. in the near-term.
Related articles »